Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Coronavirus Update: May 5

May 5, 2021/Roundup

PASC, post-COVID-19 neuropathy, herd immunity, and more.

Our Commitment to Progress

Mar 1, 2022/Statement

Our profession provides essential care. Whatever your setting, whatever your role in our physical therapy community, you are contributing to how we respond to and move through COVID-19.

A New Review Process, More Cost Transparency: CAPTE Looks Ahead

Jun 6, 2022/Roundup

The profession's education accreditation body is achieving current goals while shaping the future. Here's an overview of what's happening.

The Good Stuff: Members and the Profession in the Media, January 2023

Jan 18, 2023/Roundup

A student PT helps in Ukraine, the potential of telerehab, PSA management and more in this month's collection of APTA members and the profession in the media.

Elevate Your Practice With APTA's Comprehensive Lecture Series Bundle

Jun 21, 2024/News

Looking to expand your expertise in physical therapy? Time is running out to enroll in APTA’s comprehensive bundle of engaging lectures.

APTA Works With Congress to Address TRICARE Payment Issues

Jun 9, 2025/Article

APTA is actively working with congressional leaders to address reports of remaining TRICARE payment and operational issues impacting physical therapy providers. These issues, which emerged at the start of 2025 when TriWest Healthcare Alliance took over as the Managed Care Support Contractor under the

Member Value | Close Out the Year Strong — and Step Into 2026 With Momentum

Dec 1, 2025/Column

As the year winds down, there’s no better time to make a plan to invest in yourself and your career.

Segmental mobility and pain provocation

Aug 30, 2017/Test & Measure

Measures the posterior-to-anterior mobility of the spinal segment with/without pain provocation.

Graded Symptom Checklist (GSC)

May 23, 2017/Test & Measure

Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.

Risk Assessment Prediction Tool (RAPT)

May 23, 2017/Test & Measure

Risk Assessment Prediction Tool (RAPT)